Workflow
洁净应用材料
icon
Search documents
新莱应材(300260) - 300260新莱应材投资者关系管理信息20250827
2025-08-27 09:02
昆山新莱洁净应用材料股份有限公司投资者关系活动记录表 编号:2025-003 | | 特定对象调研 | 分析师会议 | | --- | --- | --- | | 投资者关系活动 | 媒体采访 | 业绩说明会 | | 类别 | 新闻发布会 | 路演活动 | | | 现场参观 | | | | 其他(电话会议) | | | | 深圳市国晖投资有限公司:吴昊龙 | | | | 广东正圆私募基金管理有限公司:黎君仪 | | | | 天风证券股份有限公司上海证券自营分公司:杜玙 | | | | 上海雷钧资产管理有限公司:李武跃 | | | | 野村东方国际证券有限公司:李之婧 | | | | 中泰证券股份有限公司:冯光亮 | | | | 国泰海通证券股份有限公司:黄行辉、肖隽翀 | | | | 广东恒阔投资管理有限公司:张津源 | | | | 深圳前海道谊投资控股有限公司:颜丙占 | | | | 北京泽铭投资有限公司:单河 | | | | 广深联合控股有限公司:程少普 | | | 参与单位名称及 | 广发证券股份有限公司:王宁 | | | 人员姓名 | 中信建投证券股份有限公司:吴雨瑄、赵子鹏 | | ...
【私募调研记录】明汯投资调研新莱应材、华润微
Zheng Quan Zhi Xing· 2025-05-01 00:09
Group 1: New Lai Materials - New Lai Materials specializes in clean application materials and high-purity materials, with projected revenue of 2.849 billion yuan in 2024, representing a year-on-year growth of 5.08% [1] - The company benefits from the trend of semiconductor localization, with a forecasted revenue decline of 2.33% in Q1 2025 [1] - The semiconductor market is expected to reach 611.2 billion USD in 2024, while the sterile packaging market is projected to reach 19.49 billion USD by 2031 [1] - New Lai Materials has entered the sterile packaging market through the acquisition of Shandong Bihai and is now part of the supply chain for top domestic and international companies [1] - The company aims to continue promoting domestic substitution, focusing on the semiconductor equipment and component market, and adheres to a "equipment + packaging materials" model [1] Group 2: China Resources Microelectronics - China Resources Microelectronics is focusing on high-growth areas such as automotive electronics and new energy, with expected growth rates of 15% for MOSFETs and 50% for IGBTs [2] - The gross margin is projected to decline by 1.1 percentage points in Q1 2025 due to increased depreciation from the launch of a high-end mask factory and a decrease in IC product prices [2] - The company anticipates capital expenditures of 2 billion yuan in 2025, primarily for capacity ramp-up and equipment investment in packaging and testing [2] - The utilization rate of the 12-inch production line in Chongqing is 70%, while the Shenzhen 12-inch production line is in the capacity ramp-up phase [2] - The product mix includes automotive electronics (21%), new energy (20%), home appliances (18%), industrial equipment (16%), and communication equipment (9%) [2] - The silicon carbide product line is expanding, with automotive-grade SiC MOS and SiC modules undergoing testing with automotive companies [2] - The industry is showing a mild recovery trend, with product prices expected to stabilize within a certain range [2]
新莱应材(300260):点评:国内半导体行业需求强劲,看好零部件业务增长带动业绩修复
SINOLINK SECURITIES· 2025-04-29 13:48
Investment Rating - The report maintains a "Buy" rating for the company, expecting a price increase of over 15% in the next 6-12 months [5][12]. Core Insights - In 2024, the company achieved a revenue of 2.849 billion RMB, a year-on-year increase of 5.08%, but the net profit attributable to shareholders decreased by 4.05% to 226 million RMB [2]. - The semiconductor equipment market is expected to see strong demand, with projected net profits for 2025, 2026, and 2027 at 328 million RMB, 491 million RMB, and 669 million RMB respectively, reflecting growth rates of 44.77%, 49.78%, and 36.22% [5][9]. - The company is focusing on clean application materials and high-purity materials, with significant growth in the semiconductor sector, which saw a revenue increase of 29.9% in 2024 [4]. Summary by Sections Financial Performance - In Q1 2025, the company reported a slight revenue decline of 2.33% year-on-year, with a net profit decrease of 25.56% [2][3]. - The comprehensive gross margin for 2024 was 25.72%, while Q1 2025 saw a decline to 23.82% [3]. - The company’s revenue for 2024 was 2.849 billion RMB, with a projected revenue of 3.506 billion RMB for 2025, indicating a growth rate of 23.04% [9]. Market Outlook - The report highlights a strong demand for semiconductor equipment in China, which is expected to drive domestic production and market share recovery for the company [4][5]. - The food and pharmaceutical sectors are showing moderate recovery, with revenues of 1.680 billion RMB and 305 million RMB respectively in 2024 [4]. Valuation Metrics - The projected earnings per share (EPS) for 2025, 2026, and 2027 are 0.80 RMB, 1.20 RMB, and 1.64 RMB respectively, with corresponding price-to-earnings (P/E) ratios of 39, 26, and 19 [5][9].